A PIAS1 Protective Variant S510G Delays polyQ Disease Onset by Modifying Protein Homeostasis-Reference-Cited by-同舟云学术

A PIAS1 Protective Variant S510G Delays polyQ Disease Onset by Modifying Protein Homeostasis

Published:2021-12-23 Issue: Volume: Page:
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Movement Disorders

Author:

Lee Yan Hua¹²,Tsai Yu‐Shuen³,Chang Che‐Chang⁴,Ho Chun‐Chen²,Shih Hsiu‐Ming²,Chen Hui‐Mei²,Lai Hsing‐Lin²,Lee Chia‐Wei²,Lee Yi‐Chung⁵,Liao Yi‐Chu⁵,Yang Ueng‐Cheng³⁶,Cheng Tzu‐Hao¹⁷,Chern Yijuang¹²^ORCID,Soong Bing‐Wen⁵⁸

Affiliation:

1. Taiwan International Graduate Program in Molecular Medicine National Yang Ming Chiao Tung University and Academia Sinica Taipei Taiwan

2. Institute of Biomedical Sciences, Academia Sinica Taipei Taiwan

3. Center for Systems and Synthetic Biology National Yang Ming Chiao Tung University Taipei Taiwan

4. The Ph.D. Program for Translational Medicine and International Ph.D. Program for Translational Science, College of Medical Science and Technology Taipei Medical University Taipei Taiwan

5. Department of Neurology, Taipei Veterans General Hospital, and Brain Research Center National Yang Ming Chiao Tung University Taipei Taiwan

6. Institute of Biomedical Informatics National Yang Ming Chiao Tung University Taipei Taiwan

7. Institute of Biochemistry and Molecular Biology, and Brain Research Center National Yang Ming Chiao Tung University Taipei Taiwan

8. Department of Neurology, Shuang Ho Hospital, and Taipei Neuroscience Institute Taipei Medical University Taipei Taiwan

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mds.28896

Reference49 articles.

1. Huntington's disease: from molecular pathogenesis to clinical treatment

2. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes

3. Trinucleotide repeat length instability and age of onset in Huntington's disease

4. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease

5. CAG Repeat Not Polyglutamine Length Determines Timing of Huntington’s Disease Onset

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Equilibrative nucleoside transporter 3 supports microglial functions and protects against the progression of Huntington’s disease in the mouse model;Brain, Behavior, and Immunity;2024-08

2. Caffeine Consumption and Interaction with ADORA2A, CYP1A2 and NOS1 Variants Do Not Influence Age at Onset of Machado-Joseph Disease;The Cerebellum;2024-07-06

3. CryoViT: Efficient Segmentation of Cryogenic Electron Tomograms with Vision Foundation Models;2024-06-30

4. Caffeine consumption and interaction with ADORA2A, CYP1A2 and NOS1 variants do not influence age at onset of Machado-Joseph disease;2024-05-02

5. SUMO modification in Huntington's disease: Unraveling complex mechanisms for therapeutic insights;Huntington's Disease;2024